Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
- 1 September 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 336 (8714), 529-532
- https://doi.org/10.1016/0140-6736(90)92086-w
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomesBiochemical Pharmacology, 1990
- The Polymerase Chain ReactionNew England Journal of Medicine, 1990
- Relevance of genetic polymorphism in drug metabolism in the development of new drugsEuropean Journal of Clinical Pharmacology, 1989
- Amplification of DNA from Epithelial Cells in UrineNew England Journal of Medicine, 1989
- The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal LociDNA, 1989
- Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in manBiochemistry, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1977
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977